Phil McEwan

发表论文 15 篇 · 总被引 99 次 · h-index 6

代表论文

• Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial (2024 · Clinical Kidney Journal · 被引 21)
• Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes (2025 · Journal of Medical Economics · 被引 18)
• The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis (2024 · Nephrology, Dialysis and Transplantation · 被引 16)
• Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK (2014 · Diabetes Therapy · 被引 13)
• Cost‐effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA‐HF and DELIVER data (2024 · European Journal of Heart Failure · 被引 8)
• Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis (2023 · Journal of Medical Economics · 被引 7)